PI
TEVA icon

PEAK6 Investments’s Teva Pharmaceuticals TEVA Stock Holding History

PEAK6 Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50,000
Closed -$813K – 4071
2024
Q2 		$813K Buy
+50,000
New +$770K ﹤0.01% 1970
2024
Q1 		– Sell
-998,100
Closed -$10.4M – 4732
2023
Q4 		$10.4M Hold
998,100
– – 0.04% 461
2023
Q3 		$10.2M Sell
998,100
-373,600
-27% -$3.48M 0.05% 389
2023
Q2 		$10.3M Buy
1,371,700
+74,600
+6% +$605K 0.05% 350
2023
Q1 		$11.5M Sell
1,297,100
-4,368,900
-77% -$43.2M 0.06% 333
2022
Q4 		$51.7M Sell
5,666,000
-1,280,100
-18% -$11.2M 0.3% 49
2022
Q3 		$56.1M Buy
6,946,100
+838,900
+14% +$7.42M 0.23% 55
2022
Q2 		$45.9M Buy
6,107,200
+5,987,700
+5,011% +$52.2M 0.09% 193
2022
Q1 		$1.12M Sell
119,500
-27,000
-18% -$225K ﹤0.01% 2389
2021
Q4 		$1.17M Buy
146,500
+126,200
+622% +$1.14M ﹤0.01% 2420
2021
Q3 		$198K Sell
20,300
-35,500
-64% -$332K ﹤0.01% 3992
2021
Q2 		$552K Sell
55,800
-9,100
-14% -$96.3K ﹤0.01% 3138
2021
Q1 		$749K Sell
64,900
-136,500
-68% -$1.57M ﹤0.01% 2835
2020
Q4 		$1.94M Sell
201,400
-317,500
-61% -$3.04M ﹤0.01% 1877
2020
Q3 		$4.67M Buy
518,900
+171,200
+49% +$1.81M 0.01% 992
2020
Q2 		$4.29M Buy
347,700
+39,100
+13% +$442K 0.01% 913
2020
Q1 		$2.77M Sell
308,600
-150,500
-33% -$1.54M 0.02% 831
2019
Q4 		$4.5M Sell
459,100
-175,500
-28% -$1.57M 0.02% 674
2019
Q3 		$4.37M Sell
634,600
-403,100
-39% -$3.09M 0.03% 752
2019
Q2 		$9.58M Buy
1,037,700
+362,900
+54% +$4.38M 0.06% 380
2019
Q1 		$10.6M Buy
674,800
+513,400
+318% +$9.05M 0.06% 345
2018
Q4 		$2.49M Buy
161,400
+111,400
+223% +$2.28M 0.02% 1080
2018
Q3 		$1.08M Buy
+50,000
New +$1.16M ﹤0.01% 1931

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PEAK6 Investments's TEVA Position: Q3 2024 in Review

PEAK6 Investments reduced its Teva Pharmaceuticals (TEVA) stake by 48% in Q3 2024, selling an estimated $484K and leaving 30,000 shares worth $541K. The position accounts for ﹤0.01% of the portfolio, ranked #2267.

PEAK6 Investments first reported a position in TEVA in Q3 2018 and has held it in 22 quarters since. The position peaked at $6.8M in Q3 2022. 542 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • PEAK6 Investments held 30,000 shares of Teva Pharmaceuticals worth $541K as of Q3 2024.
  • PEAK6 Investments sold 27,666 Teva Pharmaceuticals shares in Q3 2024, an estimated $484K.
  • Teva Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2267 holding.
  • PEAK6 Investments first reported a position in Teva Pharmaceuticals in Q3 2018 and has held it in 22 quarters since.
  • PEAK6 Investments's Teva Pharmaceuticals position peaked at $6.8M in Q3 2022.
  • 542 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.